Antiparasitic Drugs Global Market Report 2026

Description

Antiparasitic drugs are medications used to treat infections caused by different parasites that can affect humans, animals, or plants. Parasites are organisms that live on or inside a host and derive nutrients from it, often causing harm to the host. Antiparasitic drugs act by either killing these parasites or inhibiting their growth.

The main categories of antiparasitic drugs include anthelmintics, antiprotozoals, ectoparasiticides, and others. Anthelmintics are a class of drugs used to treat infections caused by parasitic worms. They function by either killing the parasites or preventing their growth and reproduction. The treatments include various types such as avermectins, benzimidazoles, pyrimidines, organophosphates, and imidazole thiazoles, which can be administered orally, by injection, or topically. These drugs are used by end users including hospitals, home care providers, specialty clinics, and others.

Tariffs have influenced the antiparasitic drugs market by raising the cost of imported active pharmaceutical ingredients and finished products, leading to higher production costs and pricing pressures. Segments such as anthelmintics and antiprotozoals, especially in injectable and oral forms, are most affected, with regions like North America and Europe facing supply chain disruptions. While tariffs have posed challenges for manufacturers, they also encourage local production and innovation in novel antiparasitic agents, offering potential long-term benefits for domestic markets.

The antiparasitic drugs market research report is one of a series of new reports from The Business Research Company that provides antiparasitic drugs market statistics, including antiparasitic drugs industry global market size, regional shares, competitors with a antiparasitic drugs market share, detailed antiparasitic drugs market segments, market trends and opportunities, and any further data you may need to thrive in the antiparasitic drugs industry. This antiparasitic drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antiparasitic drugs market size has grown strongly in recent years. It will grow from $25.58 billion in 2025 to $27.18 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing prevalence of parasitic diseases, limited access to modern antiparasitic drugs in developing regions, traditional reliance on monotherapy drugs, rising veterinary care demand, lack of awareness about preventive measures.

The antiparasitic drugs market size is expected to see strong growth in the next few years. It will grow to $36.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growth in combination therapy adoption, advancements in precision medicine for parasitic infections, increasing focus on animal health and livestock protection, expansion of emerging markets, development of novel delivery systems for antiparasitic drugs. Major trends in the forecast period include rising incidence of parasitic infections, development of combination antiparasitic drugs, expansion of animal healthcare applications, growth of oral and injectable treatment preferences, emergence of novel antiparasitic agents.

The rising incidence of vector-borne diseases is expected to drive the growth of the antiparasitic drugs market in the coming years. Vector-borne diseases are infectious illnesses transmitted to humans or other animals through the bites of arthropods, primarily insects such as mosquitoes, ticks, and flies. Examples of vector-borne diseases include malaria, dengue, and yellow fever. Antiparasitic drugs play a crucial role in controlling these diseases by targeting and eliminating the parasites responsible. Commonly used antiparasitic drugs for malaria include chloroquine, doxycycline, and atovaquone-proguanil. For instance, in June 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that from January to June 2024, over 9.7 million dengue cases were recorded across the Americas, more than double the 4.6 million cases reported in 2023. In the United States, Puerto Rico reported 1,498 dengue cases, and 745 cases were identified among U.S. travelers returning from affected regions. Therefore, the increasing incidence of vector-borne diseases is supporting the growth of the antiparasitic drugs market.

Major companies in the antiparasitic drugs market are focusing on developing innovative products such as chewable veterinary treatments to improve ease of administration and enhance pet compliance. Chewable veterinary products are flavored, easy-to-administer tablets or treats designed to deliver medication to animals in a palatable and stress-free way. For instance, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a Germany-based pharmaceutical company, launched NexGard Spectra to provide comprehensive parasite control. NexGard Spectra is a soft, flavorful chew that offers complete internal and external parasite protection for dogs, targeting fleas, ticks, heartworms, and various intestinal worms in a single monthly dose. It acts rapidly, killing fleas within four hours of administration and achieving over 99% effectiveness against multiple parasites shortly thereafter.

In July 2023, Bayer AG, a Germany-based multinational pharmaceutical and life sciences company, partnered with the Tropical and Public Health Institute (Swiss TPH) to develop innovative treatments against soil-transmitted helminths. The collaboration aims to advance the discovery and development of effective antiparasitic therapies, improve global access to treatment for affected populations, and strengthen research capabilities in tropical medicine, supporting sustainable health solutions in regions burdened by parasitic infections. The Tropical and Public Health Institute is a Switzerland-based research organization specializing in tropical and public health, with a focus on the prevention and control of infectious diseases.

Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim Group, Zoetis Inc., Eisai Co. Ltd., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier

North America was the largest region in the antiparasitic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antiparasitic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antiparasitic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antiparasitic drugs market consists of sales of antimalarial drugs, antiamoebic drugs, anti-trematode drugs and veterinary products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antiparasitic Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses antiparasitic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antiparasitic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antiparasitic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product Type: Anthelmintics; Antiprotozoals; Ectoparasiticide; Other Products
2) By Treatment: Avermectins; Bezimidazoles; Pyrimidines; Imidazolesthiazoles
3) By Route of Administration: Oral; Injectable; Topical
4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles; Ivermectin; Pyrantel Pamoate; Praziquantel
2) By Antiprotozoals: Metronidazole; Tinidazole; Nitazoxanide; Pentamidine
3) By Ectoparasiticides: Permethrin; Malathion; Fipronil
4) By Other Products: Combination Antiparasitic Drugs; Novel Antiparasitic Agents
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Cadila Pharmaceuticals; Merck & Co. Inc.; Bayer AG; Novartis AG; Sanofi S.A.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Boehringer Ingelheim Group; Zoetis Inc.; Eisai Co. Ltd.; Dr. Reddy's Laboratories; Intas Pharmaceuticals Ltd.; Alkem Laboratories Ltd.; Ceva Sante Animale S.A.; Elanco Animal Health Incorporated; Phibro Animal Health Corporation; Norbrook Laboratories Ltd.; Mankind Pharma; Bimeda Inc.; Indoco Remedies Ltd.; ECO Animal Health; Lincoln Pharmaceuticals Ltd.; Laboratorios Calier
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MADRU06_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Antiparasitic Drugs Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Antiparasitic Drugs Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Antiparasitic Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Antiparasitic Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
4.2. Major Trends
- 4.2.1 Rising Incidence Of Parasitic Infections
- 4.2.2 Development Of Combination Antiparasitic Drugs
- 4.2.3 Expansion Of Animal Healthcare Applications
- 4.2.4 Growth Of Oral And Injectable Treatment Preferences
- 4.2.5 Emergence Of Novel Antiparasitic Agents

5. Antiparasitic Drugs Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Homecare
5.3 Specialty Clinics
5.4 Veterinary Clinics
5.5 Pharmacies

6. Antiparasitic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Antiparasitic Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Antiparasitic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Antiparasitic Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Antiparasitic Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Antiparasitic Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Antiparasitic Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Antiparasitic Drugs Market Segmentation

9.1. Global Antiparasitic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
9.2. Global Antiparasitic Drugs Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Avermectins, Bezimidazoles, Pyrimidines, Imidazolesthiazoles
9.3. Global Antiparasitic Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Injectable, Topical
9.4. Global Antiparasitic Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Homecare, Specialty Clinics, Other End Users
9.5. Global Antiparasitic Drugs Market, Sub-Segmentation Of Anthelmintics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
9.6. Global Antiparasitic Drugs Market, Sub-Segmentation Of Antiprotozoals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
9.7. Global Antiparasitic Drugs Market, Sub-Segmentation Of Ectoparasiticides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Permethrin, Malathion, Fipronil
9.8. Global Antiparasitic Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Combination Antiparasitic Drugs, Novel Antiparasitic Agents

10. Antiparasitic Drugs Market Regional And Country Analysis

10.1. Global Antiparasitic Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Antiparasitic Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Antiparasitic Drugs Market

11.1. Asia-Pacific Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Antiparasitic Drugs Market

12.1. China Antiparasitic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Antiparasitic Drugs Market

13.1. India Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Antiparasitic Drugs Market

14.1. Japan Antiparasitic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Antiparasitic Drugs Market

15.1. Australia Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Antiparasitic Drugs Market

16.1. Indonesia Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Antiparasitic Drugs Market

17.1. South Korea Antiparasitic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Antiparasitic Drugs Market

18.1. Taiwan Antiparasitic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Antiparasitic Drugs Market

19.1. South East Asia Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Antiparasitic Drugs Market

20.1. Western Europe Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Antiparasitic Drugs Market

21.1. UK Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Antiparasitic Drugs Market

22.1. Germany Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Antiparasitic Drugs Market

23.1. France Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Antiparasitic Drugs Market

24.1. Italy Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Antiparasitic Drugs Market

25.1. Spain Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Antiparasitic Drugs Market

26.1. Eastern Europe Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Antiparasitic Drugs Market

27.1. Russia Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Antiparasitic Drugs Market

28.1. North America Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Antiparasitic Drugs Market

29.1. USA Antiparasitic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Antiparasitic Drugs Market

30.1. Canada Antiparasitic Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Antiparasitic Drugs Market

31.1. South America Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Antiparasitic Drugs Market

32.1. Brazil Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Antiparasitic Drugs Market

33.1. Middle East Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Antiparasitic Drugs Market

34.1. Africa Antiparasitic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Antiparasitic Drugs Market, Segmentation By Product Type, Segmentation By Treatment, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Antiparasitic Drugs Market Regulatory and Investment Landscape

36. Antiparasitic Drugs Market Competitive Landscape And Company Profiles

36.1. Antiparasitic Drugs Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Antiparasitic Drugs Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Antiparasitic Drugs Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Cadila Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Antiparasitic Drugs Market Other Major And Innovative Companies

Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim Group, Zoetis Inc., Eisai Co. Ltd., Dr. Reddy's Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma

38. Global Antiparasitic Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Antiparasitic Drugs Market

40. Antiparasitic Drugs Market High Potential Countries, Segments and Strategies

40.1 Antiparasitic Drugs Market In 2030 - Countries Offering Most New Opportunities
40.2 Antiparasitic Drugs Market In 2030 - Segments Offering Most New Opportunities
40.3 Antiparasitic Drugs Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer